Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
53,512,273
-
Total 13F shares
-
14,994,295
-
Share change
-
+1,899,414
-
Total reported value
-
$544,369,297
-
Put/Call ratio
-
477%
-
Price per share
-
$36.31
-
Number of holders
-
73
-
Value change
-
+$71,407,472
-
Number of buys
-
50
-
Number of sells
-
16
Institutional Holders of Zenas BioPharma, Inc. - COMMON STOCK (ZBIO) as of Q4 2025
As of 31 Dec 2025,
Zenas BioPharma, Inc. - COMMON STOCK (ZBIO) was held by
73 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,994,295 shares.
The largest 10 holders included
SR One Capital Management, LP, FEDERATED HERMES, INC., BlackRock, Inc., VANGUARD GROUP INC, Vivo Capital, LLC, Pivotal bioVenture Partners Investment Advisor LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, NEXTBio Capital Management LP, and CHARLES SCHWAB INVESTMENT MANAGEMENT INC.
This page lists
73
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.